Friday, July 10, 2026

pharma · Relapsed or Refractory Multiple Myeloma (RRMM) · Relapsed and/or Refractory Multiple Myeloma

Celgene

News and analysis for Celgene on NovaPharmaNews — regulatory, clinical, and market coverage.

Summit, USA HQ
2,104 Employees
EMA registrant Type
Company details
Status
Public
HQ
Summit, USA
Employees
2,104
Programs
45
Drugs
91
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Celgene — regulatory, clinical, and market coverage.

News and analysis for Celgene on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Celgene yet.

Back to company overview →